CTSO - Cytosorbents Corp

0.9905
0.021   2.070%

Share volume: 50,915
Last Updated: 04-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$0.97
0.02
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
17%
Profitability 0%
Dept financing 26%
Liquidity 25%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.05%
1 Month
-0.95%
3 Months
2.11%
6 Months
-12.35%
1 Year
2.93%
2 Year
-69.98%
Key data
Stock price
$0.99
P/E Ratio 
0.00
DAY RANGE
$0.93 - $1.02
EPS 
-$0.32
52 WEEK RANGE
$0.70 - $1.61
52 WEEK CHANGE
$1.08
MARKET CAP 
81.644 M
YIELD 
N/A
SHARES OUTSTANDING 
54.430 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
1.06
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$69,835
AVERAGE 30 VOLUME 
$74,203
Company detail
CEO: Phillip P. Chan
Region: US
Website: cytosorbents.com
Employees: 220
IPO year: 2008
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices. Its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals.

Recent news
loading